Final Results from TACTI-002 Part C: A Phase II Study of Eftilagimod Alpha (soluble LAG-3 Protein) and Pembrolizumab in Patients with Metastatic 2nd Line Head and Neck Squamous Cell Carcinoma Unselected for PD-L1.
JOURNAL OF CLINICAL ONCOLOGY（2023）
Key words
Stereotactic Body Radiation Therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined